Patents Assigned to EUMEDERIS PHARMACEUTICALS, INC.
  • Peptide pharmaceuticals
    Patent number: 10010617
    Abstract: Described herein are methods of syntheses and therapeutic uses of covalently modified peptides and/or proteins. The covalently modified peptides and/or proteins allow for improved pharmaceutical properties of peptide and protein-based therapeutics.
    Type: Grant
    Filed: May 17, 2012
    Date of Patent: July 3, 2018
    Assignee: EUMEDERIS PHARMACEUTICALS, INC.
    Inventor: John J. Nestor
  • Peptide pharmaceuticals
    Patent number: 10005817
    Abstract: Described herein are methods of syntheses and therapeutic uses of covalently modified peptides and/or proteins. The covalently modified peptides and/or proteins allow for improved pharmaceutical properties of peptide and protein-based therapeutics.
    Type: Grant
    Filed: November 20, 2013
    Date of Patent: June 26, 2018
    Assignee: EUMEDERIS PHARMACEUTICALS, INC.
    Inventor: John J. Nestor